315 related articles for article (PubMed ID: 23841699)
1. Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.
Zhang H; Wu J; Dong H; Khan SA; Chu ML; Tsuda T
Clin Sci (Lond); 2014 Feb; 126(4):275-88. PubMed ID: 23841699
[TBL] [Abstract][Full Text] [Related]
2. Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.
Khan SA; Dong H; Joyce J; Sasaki T; Chu ML; Tsuda T
Lab Invest; 2016 Jul; 96(7):773-83. PubMed ID: 27111286
[TBL] [Abstract][Full Text] [Related]
3. Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarction.
Tsuda T; Wu J; Gao E; Joyce J; Markova D; Dong H; Liu Y; Zhang H; Zou Y; Gao F; Miller T; Koch W; Ma X; Chu ML
J Mol Cell Cardiol; 2012 Jan; 52(1):273-82. PubMed ID: 22100229
[TBL] [Abstract][Full Text] [Related]
4. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
5. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
Pellieux C; Sauthier T; Aubert JF; Brunner HR; Pedrazzini T
J Hypertens; 2000 Sep; 18(9):1307-17. PubMed ID: 10994762
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
Zhang Y; Yan H; Guang GC; Deng ZR
Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
[TBL] [Abstract][Full Text] [Related]
11. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
Sriramula S; Francis J
PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated miR-192-5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2-mediated TGF-β1 signaling pathway.
Tang CZ; Yang JT; Liu QH; Wang YR; Wang WS
FASEB J; 2019 Jan; 33(1):606-618. PubMed ID: 30118321
[TBL] [Abstract][Full Text] [Related]
13. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
14. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
15. Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.
Rodrigues Díez R; Rodrigues-Díez R; Lavoz C; Rayego-Mateos S; Civantos E; Rodríguez-Vita J; Mezzano S; Ortiz A; Egido J; Ruiz-Ortega M
PLoS One; 2010 Nov; 5(11):e14145. PubMed ID: 21152444
[TBL] [Abstract][Full Text] [Related]
16. Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade.
Moltzer E; te Riet L; Swagemakers SM; van Heijningen PM; Vermeij M; van Veghel R; Bouhuizen AM; van Esch JH; Lankhorst S; Ramnath NW; de Waard MC; Duncker DJ; van der Spek PJ; Rouwet EV; Danser AH; Essers J
PLoS One; 2011; 6(8):e23411. PubMed ID: 21858106
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy.
Chen S; Lee JS; Iglesias-de la Cruz MC; Wang A; Izquierdo-Lahuerta A; Gandhi NK; Danesh FR; Wolf G; Ziyadeh FN
Nephrol Dial Transplant; 2005 Jul; 20(7):1320-8. PubMed ID: 15840669
[TBL] [Abstract][Full Text] [Related]
18. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
20. Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models.
Hiromura M; Mori Y; Kohashi K; Terasaki M; Shinmura K; Negoro T; Kawashima H; Kogure M; Wachi T; Watanabe R; Sato K; Kushima H; Tomoyasu M; Nakano Y; Yamada Y; Watanabe T; Hirano T
Circ J; 2016 Aug; 80(9):1988-97. PubMed ID: 27375170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
